Cancer Research UK logo.
SearchDonate
  • Search

A study of stereotactic ablative radiotherapy for lung cancer (SABRTOOTH)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC)

Status:

Closed

Phase:

Pilot

Details

This study is comparing stereotactic ablative radiotherapy (SABR) with surgery to treat lung cancer. It is open to people with a type of lung cancer called non small cell lung cancer (NSCLC) that is at an early cancer stage (stage 1) and can be treated with either surgery or SABR with the aim to cure.

Recruitment start: 1 July 2015

Recruitment end: 31 January 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Kevin Franks

Supported by

Leeds Teaching Hospitals NHS Trust

NIHR Clinical Research Network: Cancer

National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB)

Last reviewed: 31 January 2017

CRUK internal database number: 12724

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.